Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393

British Journal of Pharmacology

Volumn 126, Issue 8, 1999, Pages 1847-1855

  Castro, Newton G ^a   De Mello, Maria Christina F ^a   De Mello, Fernando G ^a   Aracava, Yasco ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Dopamine; Glutamate; Ion channel; NMDA receptor; SKF38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; MAGNESIUM CHLORIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CHICKEN; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; DRUG MECHANISM; EMBRYO; FETUS; HIPPOCAMPUS; HYPERPOLARIZATION; NERVE CELL CULTURE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RETINA NERVE CELL; THALAMUS;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CARDIOTONIC AGENTS; CELLS, CULTURED; CHICK EMBRYO; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; HIPPOCAMPUS; ION CHANNEL GATING; ION CHANNELS; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NEURONS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA; STEREOISOMERISM; THALAMUS;

EID: 0032903504     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702479     Document Type: Article

References (31)

1. Akaike, A., Ohno, Y., Sasa, M. & Takaori, S. (1987). Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro. Brain Res., 418, 262-272.
2. Alkondon, M. & Albuquerque, E.X. (1993). Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exper. Therap., 265, 1455-1473.
3. 1 receptor efficacy. Eur. J. Pharmacol., 188, 335-347.
4. Ascher, P. & Nowak, L. (1988). The role of divalent cations in the N-methyl-d-aspartate responses of mouse central neurones in culture. J. Physiol. (London), 399, 247-266.
5. Braun, A., Fabbrini, G., Mouradian, M.M., Serrati, C., Barone, P. & Chase, T.N. (1987). Selective D-1 dopamine receptor agonist treatment of Parkinson's disease. J. Neural Transm., 68, 41-50.
6. Braun, A., Mouradian, M.M., Mohr, E., Fabbrini, G. & Chase, T.N. (1989). Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders. J. Neurol. Neurosurg. Psychiatry, 52, 631-635.
7. Castro, N.G., Aracava, Y., Albuquerque, E.X., do Nascimento, J.L.M., de Mello, M.C.F. & de Mello, F.G. (1995). Fast inhibition of N-methyl-D-aspartate (NMDA) receptor function: An atypical effect of dopamine. Soc. Neurosci. Abs., 21, 1372 (Abstract).
8. Cepeda, C., Buchwald, N.A. & Levine, M.S. (1993). Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. Natl. Acad. Sci. U.S.A., 90, 9576-9580.
9. do Nascimento, J.L.M. & de Mello, F.G. (1985). Induced release of gamma-aminobutyric acid by a carrier-mediated, high affinity uptake of L-glutamate in cultured chick retina cells. J. Neurochem., 45, 1820-1827.
10. do Nascimento, J.L.M., Kubrusly, R.C.C., Reis, R.A.M., de Mello, M.C.F. & de Mello, F.G. (1998). Atypical effect of dopamine in modulating the functional inhibition of NMDA receptors of cultured retina cells. Eur. J. Pharmacol., 343, 103-110.
11. Dowling, J.E. (1991). Retinal neuromodulation: The role of dopamine. Visual Neurosci., 7, 87-97.
12. Freund, T.F., Powell, J.F. & Smith, A.D. (1984). Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience, 13, 1189-1215.
13. Gandolfi, O. & Dall'Olio, R. (1996). Modulatory role of dopamine on excitatory amino acid receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry, 20, 659-671.
14. Gossel, M., Schmidt, W.J., Loscher, W., Zajaczkowski, W. & Danysz, W. (1995). Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats. J. Neural Transm. Park. Dis. Dement. Sect., 10, 27-39.
15. 1 receptor activation. J. Physiol. (London), 492, 143-154.
16. 3H]butyric acid from cultured amacrine-like neurons mediated by different excitatory amino acid receptors. J. Neurochem., 56, 923-932.
17. Jackisch, R., Kruchen, A., Sauermann, W., Hertting, G. & Feuerstein, T.J. (1994). The antiparkinsonian drugs budipine and biperiden are use-dependent (uncompetitive) NMDA receptor antagonists. Eur. J. Pharmacol., 264, 207-211.
18. Kaiser, C., Dandridge, P.A., Garvey, E., Hahn, R.A., Sarau, H.M., Setler, P.E., Bass, L.S. & Clardy, J. (1982). Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine. J. Med. Chem., 25, 697-703.
19. Knapp, A.G. & Dowling, J.E. (1987). Dopamine enhances excitatory amino acid-gated conductances in cultured retinal horizontal cells. Nature, 325, 437-439.
20. Knapp, A.G., Schmidt, K.-F. & Dowling, J.E. (1990). Dopamine modulates the kinetics of ion channels gated by excitatory amino acids in retinal horizontal cells. Proc. Natl. Acad. Sci. U.S.A., 87, 767-771.
21. Kornhuber, J. & Kornhuber, M.E. (1983). Axo-axonic synapses in the rat striatum. Eur. Neurol., 22, 433-436.
22. Kornhuber, J., Weller, M., Schoppmeyer, K. & Riederer, P. (1994). Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J. Neural Transm. Suppl., 43, 91-104.
23. Lupp, A., Lücking, C.H., Koch, R., Jackisch, R. & Feuerstein, T.J. (1992). Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro. J. Pharmacol. Exper. Therap., 263, 717-724.
24. Magazanik, L.G., Antonov, S.M., Lukomskaya, N.Y., Potapyeva, N.N., Gmiro, V.E. & Johnson, J. (1996). Blockade of glutamate- and cholinergic ion channels by amantadane derivatives. Neurosci. Behav. Physiol., 26, 13-22.
25. Matsubayashi, H., Swanson, K.L. & Albuquerque, E.X. (1997). Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons. J. Pharmacol. Exper. Therap., 281, 834-844.
26. Mayer, M.L., Vyklicky, I., & Westbrook, G.L. (1989). Modulation of excitatory amino acid receptors by group HB metal cations in cultured mouse hippocampal neurons. J. Physiol. (London), 415, 329-350.
27. Parsons, C.G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S. & Danysz, W. (1995). Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology, 34, 1239-1258.
28. Schmidt, K.-F., Kruse, M. & Hatt, H. (1994). Dopamine alters glutamate receptor desensitization in retinal horizontal cells of the perch (Percafluviatilis). Proc. Natl. Acad. Sci. U.S.A., 91, 8288-8291.
29. Smith, D.O., Lowe, D., Temkin, R., Jensen, P. & Hatt, H. (1995). Dopamine enhances glutamate-activated currents in spinal motoneurons. J. Neurosci., 15, 3905-3912.
30. Sokoloff, P. & Schwartz, J.-C. (1995). Novel dopamine receptors half a decade later. Trends Pharmacol. Sci., 16, 270-275.
31. Stoof, J.C., Booij, J., Drukarch, B. & Wolters, E.C. (1992). The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriaturn in a non-competitive way. Eur. J. Pharmacol., 213, 439-443.